drugset / Trial / NCT00714740

Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude

NCT00714740

Phase 4 Completed 49 enrolled University of Zurich
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of the study is to investigate the effect of acetazolamide as a treatment for sleep related breathing disturbances in patients with the obstructive sleep apnea syndrome living at low altitude during a sojourn at moderate altitude

Timeline

Start
2008-06
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 250 mg